Navigation Links
BioCryst in Medical News
BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
...IRMINGHAM, Ala., July 30 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today anno...i.v.) peramivir in the U.S. "Our efforts at biocryst remain focused on moving our leading peramivir and...onehouse, President and Chief Executive Officer of biocryst Pharmaceuticals. "BioCryst continues to work dili......RMINGHAM, Ala., May 14 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ... of the nine subjects, respectively. About biocryst biocryst is a biopharmaceutical company that has developed ...
BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
...RMINGHAM, Ala., Feb. 2 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today anno...eb cast of the presentation may be accessed on the biocryst Web site at http://www.biocryst.com . The presentation will be archived for 14 days. About biocryst ......IRMINGHAM, Ala., Jan. 30 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...n Friday, February 6, 2009. Following the release, biocryst will host a conference call and Web cast at 8:30 a... and available for replay for 14 days. About biocryst ...
BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
...eb cast of the presentation may be accessed on the biocryst Web site at http://www.biocryst.com . The present...ll be archived for ninety days. About BioCryst biocryst is an integrated biopharmaceutical company utilizi...e of novel therapeutics targeting major illnesses. biocryst is currently advancing investigational new drugs d......ionogi & Co., Ltd. Partnership In February 2007, biocryst and Shionogi & Co., Ltd. entered into an exclusive...s rights were extended to include Taiwan. In 2007, biocryst received a $14 million up-front payment and may al...e) royalty payments on product sales of peramivir. biocryst retains all rights to commercialize peramivir in N...
BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
...n Thursday, May 8, 2008. At 8:30 a.m. Eastern Time biocryst will host a conference call and webcast to discuss...ailable for replay for 14 days. About BioCryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...amivir in seasonal and life-threatening influenza. biocryst has a worldwide partnership with Roche for the dev...BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
...day, November 8, 2007. At 10:00 a.m. Eastern Time, biocryst will host a conference call and live webcast. The ...Senior Vice President and Chief Financial Officer. biocryst management will discuss the Company's third quarte... be archived on https://www.biocryst.com . About biocryst ...BioCryst Receives Special Protocol Assessment for Fodosine
... biocryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announc...guidance on the design of pivotal trial protocols. biocryst requested the formal assessment, late in the first... their input and guidance during this SPA process. biocryst is now well positioned to begin patient enrollment...BioCryst’s Bird Flu Drug Enjoys Fast-Track Review By FD
...stration. // This novel drug, produced by the pharmaceutical company biocryst can be injected intravenously. Promising results have been obtained from dr... life-threatening strains like those associated with avian influenza," said biocryst Chairman and CEO Charles Bugg. The FDA had approved the launch of h...BioCryst in Medical Technology
...MINGHAM, Ala., July 17 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...ral treatment options for influenza remains high. biocryst is currently finalizing its plans for peramivir Ph... "This data represents a significant milestone for biocryst -- the first Phase 3 studies successfully conducte...
... BIRMINGHAM, Ala., May 7 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...ed on Friday, May 8, 2009. Following the release, biocryst will host a conference call and Web cast at 8:30 a... available for replay for 14 days. About biocryst ...
...IRMINGHAM, Ala., Feb. 23 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...vir in outpatient influenza underway. About biocryst biocryst is an integrated biopharmaceutical company utilizi...
...ddressing seasonal influenza." In February 2007, biocryst and Shionogi entered into an exclusive license agr...e) royalty payments on product sales of peramivir. biocryst retains all rights to commercialize peramivir in N... outside of Japan and Korea. Earlier this month, biocryst commenced a Phase II study of intra-muscular (i.m....
...tment of influenza infections." About BioCryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...amivir in seasonal and life-threatening influenza. biocryst is collaborating with Mundipharma for the developm...S) awarded a $102.6 million, four-year contract to biocryst to advance development of peramivir to treat seaso...
...tion previously presented at the 2006 ASH meeting. biocryst is currently enrolling subjects in a pivotal trial...tions in the treatment of CLL." About BioCryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...mivir in seasonal and life- threatening influenza. biocryst has a worldwide partnership with Roche for the dev...
...en the U.S. Food and Drug Administration (FDA) and biocryst which was granted earlier this year. The study wil...L), and chronic lymphocytic leukemia (CLL). About biocryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
... BIRMINGHAM, Ala., May 8 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today anno...uenza outbreak with significant hospitalizations. biocryst is advancing the clinical development of peramivir...ral or inhaled anti-viral medication. In addition, biocryst is in negotiations with the Division of Microbiolo...... BIRMINGHAM, Ala., May 7 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...ed on Friday, May 8, 2009. Following the release, biocryst will host a conference call and Web cast at 8:30 a... available for replay for 14 days. About biocryst ...
...IRMINGHAM, Ala., Feb. 23 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...vir in outpatient influenza underway. About biocryst biocryst is an integrated biopharmaceutical company utilizi...
...ddressing seasonal influenza." In February 2007, biocryst and Shionogi entered into an exclusive license agr...e) royalty payments on product sales of peramivir. biocryst retains all rights to commercialize peramivir in N... outside of Japan and Korea. Earlier this month, biocryst commenced a Phase II study of intra-muscular (i.m....
...tment of influenza infections." About BioCryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...amivir in seasonal and life-threatening influenza. biocryst is collaborating with Mundipharma for the developm...S) awarded a $102.6 million, four-year contract to biocryst to advance development of peramivir to treat seaso...
BioCryst Updates Peramivir Clinical Development Plan
...er dose of peramivir later this year. As a result, biocryst will not continue to pursue a pivotal Phase III pr... a successful result." After discussions between biocryst and HHS, the Company believes that peramivir remai...tially important therapy available to patients." biocryst will sponsor a conference call at 8:00 am Eastern ......tion previously presented at the 2006 ASH meeting. biocryst is currently enrolling subjects in a pivotal trial...tions in the treatment of CLL." About BioCryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...mivir in seasonal and life- threatening influenza. biocryst has a worldwide partnership with Roche for the dev...
BioCryst Provides Forodesine HCl Update
...t information presented at the 2006 ASH meeting. biocryst to Voluntarily Discontinue Clinical Study of Intra... After review and consultation with Mundipharma, biocryst has decided to voluntarily and formally discontinu...cal trial for this indication. On March 27, 2007 biocryst announced that as the result of a stability issue,......en the U.S. Food and Drug Administration (FDA) and biocryst which was granted earlier this year. The study wil...L), and chronic lymphocytic leukemia (CLL). About biocryst biocryst Pharmaceuticals, Inc. is a leader in the use of cr...
BioCryst in Biological Technology
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
BIRMINGHAM, Ala., June 18 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX ) today announced that William P. Sheridan, MB BS, has been appointed Chief Medical Officer of BioCryst, effective July 1, 2008. Dr. Sheridan is a seasoned biotechnology professional, most recently serv...BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
...IRMINGHAM, Ala., July 28 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) today announced ...ults will be released on Thursday, July 30, 2009. biocryst will host a conference call and Web cast at 11:00 ...le for replay for at least 14 days. About biocryst ...Novavax Appoints Stanley Erck to Board of Directors
...e his anticipated contributions to our future success as we expand our pipeline of promising vaccine candidates." Mr. Erck is also a Director of biocryst Pharmaceuticals, MaxCyte, Inc. and MdBio Foundation. He received his undergraduate degree from the University of Illinois and his masters in busine...Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board
...ously a member of the executive management team at biocryst Pharmaceuticals, Inc., a biopharmaceutical company. Currently, he is a Director of biocryst and serves as Chairperson of its Audit Committee. Before joining biocryst in 1994, Mr. Higgins was a member of the healthcar...Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll
...rds, and humans. "Apart from those biotech companies that are linked to combating a potential flu pandemic, such as Gilead Sciences, Novavax and biocryst Pharmaceuticals, biotech didn't fare as well as the general markets," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global...... stockhideout.com . Today's Stock Alerts include: Hemispherx Biopharma Inc. (AMEX: HEB ), Generex Biotechnology Corp. (Nasdaq: GNBT ), biocryst Pharmaceuticals Inc. (Nasdaq: BCRX ), Dynavax Technologies Corp. (Nasdaq: DVAX ), Novavax Inc. (Nasdaq: NVAX ) and Sinovac Biotech Ltd. (AMEX: ...
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
...BIRMINGHAM, Ala., Feb. 6 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today anno...hich is in-line with the Company's 2008 guidance. biocryst expects the Company's net cash use in 2009 will be... compared to placebo. biocryst will present results from the previously announced...BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
...BIRMINGHAM, Ala., Jan. 8 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today anno...eb cast of the presentation may be accessed on the biocryst Web site at www.biocryst.com . The presentation will be archived for ninety days. About biocryst ......BIRMINGHAM, Ala., Dec. 5 /PRNewswire-FirstCall/ -- biocryst Pharmaceuticals (Nasdaq: BCRX ) announced today ...:00 p.m. Pacific Time; Hall A About biocryst biocryst is an integrated biopharmaceutical company utilizi...
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
...ith i.v. peramivir in the outpatient setting. -- biocryst reported results of an exploratory Phase 2 trial o... be submitted to an upcoming medical meeting. -- biocryst reported top-line results from the completed Phase...download that may be necessary. About BioCryst biocryst is an integrated biopharmaceutical company utilizi...Other TagsOther Contents
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
(Date:5/20/2013)... InVite® Health, a leading nutraceutical firm ... of its new Greens Hx™ product; a ... with plant extracts from 39 super foods including sea ... pectin, plant enzymes and non-dairy probiotics. A small ... levels of several servings of vegetables. The product is ...
(Date:5/20/2013)... May 20, 2013 The transvaginal mesh ... device law firm, report that two important bellwether trials ... in state and federal litigations established for C.R. Bard ... the first C.R. Bard bellwether trial will begin in ... of West Virginia. (In re: C.R. Bard, Inc., ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Today is ... Perfect Interview Answers Webinar tomorrow. Job seekers ... Career Confindential’s expert career coach, will show job seekers ... Webinar attendees will also learn the perfect interview answers ... as interview techniques that will get them hired. Job ...
(Date:5/19/2013)... California has one of the largest pool of ... discovering that comprehensive background checks are playing an important role ... Driving records can paint an accurate portrait of a ... any DUI arrests, speeding offenses, and traffic violations to their ... to experience 4SafeDrivers.com, a new online service which allows users ...
Breaking Medicine News(10 mins):Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4Health News:Today Is the Last Day to Register for Tomorrow’s Perfect Interview Answers Webinar From Career Confidential 2Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2[0] MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo[0] InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™[0] Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials[0] Today Is the Last Day to Register for Tomorrow’s Perfect Interview Answers Webinar From Career Confidential[0] 4SafeDrivers.com Announces Driving Record Searches for California Employers
(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...
(Date:5/17/2013)... MD The Federation of American Societies for Experimental ... National Institutes of Health (NIH) funding trends highlighting the ... support critical research. The FASEB analysis follows a May ... Collins, MD, PhD, who testified that the $1.6 billion ... sequestration is "having a substantial impact on the scientific ...
(Date:5/16/2013)... Illustrating a commitment to the support of ... (AGA) Research Foundation has announced the inaugural AGA ... recipients. Supported by the National Institute of Diabetes ... award helps underrepresented minority students to further their ... , "By establishing this new award, AGA demonstrates ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |